Werner Reichardt Center for Integrative Neuroscience, Eberhard-Karls-University Tübingen, 72076 Tübingen, Germany.
Department of Comparative Biosciences, College of Veterinary Medicine, University of Illinois at Urbana-Champain, Urbana, IL 61802-6178 USA.
Int J Mol Sci. 2019 Jul 16;20(14):3486. doi: 10.3390/ijms20143486.
Patterns of spontaneous electric activity in the cerebral cortex change upon administration of benzodiazepines. Here we are testing the hypothesis that the prototypical benzodiazepine, diazepam, affects spectral power density in the low (20-50 Hz) and high (50-90 Hz) γ-band by targeting GABA receptors harboring α- and α-subunits. Local field potentials (LFPs) and action potentials were recorded in the barrel cortex of wild type mice and two mutant strains in which the drug exclusively acted via GABA receptors containing either α- (DZα-mice) or α-subunits (DZα-mice). In wild type mice, diazepam enhanced low γ-power. This effect was also evident in DZα-mice, while diazepam decreased low γ-power in DZα-mice. Diazepam increased correlated local LFP-activity in wild type animals and DZα- but not in DZα-mice. In all genotypes, spectral power density in the high γ-range and multi-unit action potential activity declined upon diazepam administration. We conclude that diazepam modifies low γ-power in opposing ways via α1- and α2-GABA receptors. The drug's boosting effect involves α2-receptors and an increase in local intra-cortical synchrony. Furthermore, it is important to make a distinction between high- and low γ-power when evaluating the effects of drugs that target GABA receptors.
在给予苯二氮䓬类药物后,大脑皮层的自发电活动模式会发生变化。在这里,我们假设典型的苯二氮䓬类药物地西泮通过靶向含有 α-和 α-亚基的 GABA 受体,影响低(20-50 Hz)和高(50-90 Hz)γ 波段的光谱功率密度。在野生型小鼠和两种突变株(其中药物仅通过含有 α-(DZα-小鼠)或 α-亚基(DZα-小鼠)的 GABA 受体发挥作用)的桶状皮层中记录局部场电位(LFPs)和动作电位。在野生型小鼠中,地西泮增强了低 γ 功率。在 DZα-小鼠中也可以看到这种作用,而地西泮降低了 DZα-小鼠的低 γ 功率。地西泮增加了野生型动物和 DZα-中的局部 LFP 活动的相关性,但在 DZα-小鼠中则没有。在所有基因型中,高 γ 范围内的光谱功率密度和多单位动作电位活动在给予地西泮后下降。我们得出的结论是,地西泮通过 α1-和 α2-GABA 受体以相反的方式调节低 γ 功率。该药物的增强作用涉及 α2-受体和局部皮质内同步性的增加。此外,在评估靶向 GABA 受体的药物的作用时,区分高 γ 功率和低 γ 功率很重要。